MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


Molecular Pharmacology Fast Forward
First published on June 27, 2007; DOI: 10.1124/mol.107.038075


0026-895X/07/7204-812-825$20.00
Mol Pharmacol 72:812-825, 2007

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
mol.107.038075v1
72/4/812    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Related articles in MolPharm
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yost, E. A.
Right arrow Articles by Berlot, C. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yost, E. A.
Right arrow Articles by Berlot, C. H.

Live Cell Analysis of G Protein β5 Complex Formation, Function, and Targeting

Evan A. Yost, Stacy M. Mervine, Jonathan L. Sabo, Thomas R. Hynes, and Catherine H. Berlot

Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania

The G protein β5 subunit differs from other β subunits in having divergent sequence and subcellular localization patterns. Although β5{gamma}2 modulates effectors, β5 associates with R7 family regulators of G protein signaling (RGS) proteins when purified from tissues. To investigate β5 complex formation in vivo, we used multicolor bimolecular fluorescence complementation in human embryonic kidney 293 cells to compare the abilities of 7 {gamma} subunits and RGS7 to compete for interaction with β5. Among the {gamma} subunits, β5 interacted preferentially with {gamma}2, followed by {gamma}7, and efficacy of phospholipase C-β2 activation correlated with amount of β5{gamma} complex formation. β5 also slightly preferred {gamma}2 over RGS7. In the presence of coexpressed R7 family binding protein (R7BP), β5 interacted similarly with {gamma}2 and RGS7. Moreover, {gamma}2 interacted preferentially with β1 rather than β5. These results suggest that multiple coexpressed proteins influence β5 complex formation. Fluorescent β5{gamma}2 labeled discrete intracellular structures including the endoplasmic reticulum and Golgi apparatus, whereas β5RGS7 stained the cytoplasm diffusely. Coexpression of {alpha}o targeted both β5 complexes to the plasma membrane, and {alpha}q also targeted β5{gamma}2 to the plasma membrane. The constitutively activated {alpha}o mutant, {alpha}oR179C, produced greater targeting of β5RGS7 and less of β5{gamma}2 than did {alpha}o. These results suggest that {alpha}o may cycle between interactions with β5{gamma}2 or other β{gamma} complexes when inactive, and β5RGS7 when active. Moreover, the ability of β5{gamma}2 to be targeted to the plasma membrane by {alpha} subunits suggests that functional β5{gamma}2 complexes can form in intact cells and mediate signaling by G protein-coupled receptors.


Received May 11, 2007; accepted June 26, 2007

Address correspondence to: Catherine Berlot, Weis Center for Research, Geisinger Clinic, 100 North Academy Avenue, Danville, PA 17822-2623. E-mail: chberlot{at}geisinger.edu


Related articles in MolPharm:

Illuminating Gbeta5 Signaling
Corinne E. Zeller and Henrik G. Dohlman
MolPharm 2007 72: 810-811. [Abstract] [Full Text]  



This article has been cited by other articles:


Home page
Mol. Pharmacol.Home page
C. E. Zeller and H. G. Dohlman
Illuminating Gbeta5 Signaling
Mol. Pharmacol., October 1, 2007; 72(4): 810 - 811.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics